nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—UGT1A9—Sorafenib—kidney cancer	0.333	1	CbGbCtD
Entacapone—COMT—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—kidney cancer	0.0089	0.104	CbGpPWpGaD
Entacapone—COMT—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—kidney cancer	0.00776	0.0906	CbGpPWpGaD
Entacapone—UGT1A9—renal system—kidney cancer	0.00558	0.194	CbGeAlD
Entacapone—UGT1A9—kidney—kidney cancer	0.0054	0.188	CbGeAlD
Entacapone—COMT—Biogenic Amine Synthesis—ACHE—kidney cancer	0.00538	0.0629	CbGpPWpGaD
Entacapone—COMT—nephron tubule—kidney cancer	0.00337	0.117	CbGeAlD
Entacapone—COMT—renal system—kidney cancer	0.00306	0.106	CbGeAlD
Entacapone—UGT1A9—Irinotecan Pathway—BCHE—kidney cancer	0.00297	0.0347	CbGpPWpGaD
Entacapone—COMT—Estrogen metabolism—GSTM1—kidney cancer	0.00296	0.0346	CbGpPWpGaD
Entacapone—COMT—kidney—kidney cancer	0.00296	0.103	CbGeAlD
Entacapone—COMT—cortex of kidney—kidney cancer	0.00288	0.1	CbGeAlD
Entacapone—COMT—Estrogen metabolism—CYP1A1—kidney cancer	0.00281	0.0328	CbGpPWpGaD
Entacapone—COMT—gonad—kidney cancer	0.00274	0.0955	CbGeAlD
Entacapone—COMT—cardiac atrium—kidney cancer	0.00274	0.0954	CbGeAlD
Entacapone—COMT—Biological oxidations—ACY1—kidney cancer	0.00238	0.0278	CbGpPWpGaD
Entacapone—UGT1A9—Estrogen metabolism—GSTM1—kidney cancer	0.00178	0.0208	CbGpPWpGaD
Entacapone—UGT1A9—Estrogen metabolism—CYP1A1—kidney cancer	0.00168	0.0197	CbGpPWpGaD
Entacapone—UGT1A9—Irinotecan Pathway—APC—kidney cancer	0.00161	0.0188	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUND—kidney cancer	0.0016	0.0186	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—ACY1—kidney cancer	0.00142	0.0166	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—GLIPR1—kidney cancer	0.00141	0.0165	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—GLIPR1—kidney cancer	0.00138	0.0161	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—GSTT1—kidney cancer	0.00131	0.0153	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—ALDH1A1—kidney cancer	0.0013	0.0152	CbGpPWpGaD
Entacapone—UGT1A9—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.00115	0.0135	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUNB—kidney cancer	0.00109	0.0127	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—GLIPR1—kidney cancer	0.000951	0.0111	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—GSTP1—kidney cancer	0.000906	0.0106	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SLC5A3—kidney cancer	0.000852	0.00996	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—GSTM1—kidney cancer	0.000833	0.00973	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CYP1A1—kidney cancer	0.000795	0.00929	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTT1—kidney cancer	0.000783	0.00915	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—ALDH1A1—kidney cancer	0.00078	0.00911	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTT1—kidney cancer	0.000765	0.00894	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—KEAP1—kidney cancer	0.000745	0.00871	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—PTGS1—kidney cancer	0.000717	0.00838	CbGpPWpGaD
Entacapone—COMT—Neuronal System—KCNMA1—kidney cancer	0.000702	0.00821	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000678	0.00792	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—CCND1—kidney cancer	0.000674	0.00788	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000591	0.0069	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTP1—kidney cancer	0.000543	0.00634	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—MYC—kidney cancer	0.000541	0.00632	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTP1—kidney cancer	0.00053	0.0062	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—GSTP1—kidney cancer	0.000523	0.00611	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—kidney cancer	0.000521	0.00609	CbGpPWpGaD
Entacapone—COMT—Neuronal System—ACHE—kidney cancer	0.000519	0.00607	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—GSTM1—kidney cancer	0.000499	0.00583	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—GSTM1—kidney cancer	0.000487	0.00569	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—GSTM1—kidney cancer	0.000481	0.00562	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—CYP1A1—kidney cancer	0.000462	0.0054	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTT1—kidney cancer	0.000458	0.00535	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—CYP1A1—kidney cancer	0.000456	0.00532	CbGpPWpGaD
Entacapone—COMT—Neuronal System—BCHE—kidney cancer	0.000453	0.00529	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SLC5A5—kidney cancer	0.00045	0.00525	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	0.000448	0.00523	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	0.000438	0.00512	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SLC2A1—kidney cancer	0.000434	0.00507	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—PTGS1—kidney cancer	0.000429	0.00502	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	0.000426	0.00498	CbGpPWpGaD
Entacapone—COMT—Metabolism—ACY1—kidney cancer	0.000406	0.00475	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—EGR1—kidney cancer	0.000403	0.00471	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—CYP1A1—kidney cancer	0.000396	0.00462	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—kidney cancer	0.000387	0.00452	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000379	0.00443	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GSTP1—kidney cancer	0.000362	0.00423	CbGpPWpGaD
Entacapone—COMT—Metabolism—PDHB—kidney cancer	0.000345	0.00404	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—POMC—kidney cancer	0.000344	0.00402	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GSTM1—kidney cancer	0.000333	0.00389	CbGpPWpGaD
Entacapone—COMT—Metabolism—CCBL1—kidney cancer	0.000325	0.0038	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTP1—kidney cancer	0.000318	0.00371	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—GSTP1—kidney cancer	0.000313	0.00366	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000301	0.00352	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTM1—kidney cancer	0.000292	0.00341	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—GSTM1—kidney cancer	0.000288	0.00336	CbGpPWpGaD
Entacapone—COMT—Metabolism—PPAT—kidney cancer	0.000282	0.00329	CbGpPWpGaD
Entacapone—COMT—Metabolism—GLIPR1—kidney cancer	0.000282	0.00329	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP1A1—kidney cancer	0.000277	0.00323	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP1A1—kidney cancer	0.000273	0.00319	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—kidney cancer	0.000267	0.00312	CbGpPWpGaD
Entacapone—COMT—Metabolism—FH—kidney cancer	0.000262	0.00306	CbGpPWpGaD
Entacapone—COMT—Metabolism—APRT—kidney cancer	0.000262	0.00306	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000252	0.00294	CbGpPWpGaD
Entacapone—COMT—Metabolism—GPC3—kidney cancer	0.000246	0.00288	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ACY1—kidney cancer	0.000243	0.00284	CbGpPWpGaD
Entacapone—COMT—Metabolism—CA2—kidney cancer	0.000239	0.0028	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALAD—kidney cancer	0.000233	0.00273	CbGpPWpGaD
Entacapone—COMT—Neuronal System—BRAF—kidney cancer	0.000231	0.0027	CbGpPWpGaD
Entacapone—COMT—Metabolism—ST3GAL2—kidney cancer	0.000228	0.00266	CbGpPWpGaD
Entacapone—Convulsion—Paclitaxel—kidney cancer	0.000224	0.000406	CcSEcCtD
Entacapone—Nausea—Everolimus—kidney cancer	0.000224	0.000405	CcSEcCtD
Entacapone—Diarrhoea—Sorafenib—kidney cancer	0.000224	0.000405	CcSEcCtD
Entacapone—Hypertension—Paclitaxel—kidney cancer	0.000224	0.000405	CcSEcCtD
Entacapone—COMT—Metabolism—ALDH1A1—kidney cancer	0.000223	0.0026	CbGpPWpGaD
Entacapone—Pruritus—Sunitinib—kidney cancer	0.000223	0.000403	CcSEcCtD
Entacapone—Chest pain—Paclitaxel—kidney cancer	0.00022	0.000399	CcSEcCtD
Entacapone—Myalgia—Paclitaxel—kidney cancer	0.00022	0.000399	CcSEcCtD
Entacapone—Anxiety—Paclitaxel—kidney cancer	0.00022	0.000398	CcSEcCtD
Entacapone—Decreased appetite—Gemcitabine—kidney cancer	0.000219	0.000397	CcSEcCtD
Entacapone—Hypersensitivity—Dactinomycin—kidney cancer	0.000219	0.000397	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000219	0.000396	CcSEcCtD
Entacapone—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000218	0.000394	CcSEcCtD
Entacapone—Discomfort—Paclitaxel—kidney cancer	0.000218	0.000394	CcSEcCtD
Entacapone—Fatigue—Gemcitabine—kidney cancer	0.000218	0.000394	CcSEcCtD
Entacapone—Gastrointestinal pain—Vincristine—kidney cancer	0.000218	0.000394	CcSEcCtD
Entacapone—Dizziness—Sorafenib—kidney cancer	0.000216	0.000391	CcSEcCtD
Entacapone—Constipation—Gemcitabine—kidney cancer	0.000216	0.000391	CcSEcCtD
Entacapone—Pain—Gemcitabine—kidney cancer	0.000216	0.000391	CcSEcCtD
Entacapone—Nausea—Erlotinib—kidney cancer	0.000216	0.000391	CcSEcCtD
Entacapone—Alopecia—Capecitabine—kidney cancer	0.000216	0.00039	CcSEcCtD
Entacapone—Dry mouth—Paclitaxel—kidney cancer	0.000216	0.00039	CcSEcCtD
Entacapone—Diarrhoea—Sunitinib—kidney cancer	0.000215	0.00039	CcSEcCtD
Entacapone—Ataxia—Doxorubicin—kidney cancer	0.000214	0.000387	CcSEcCtD
Entacapone—Mental disorder—Capecitabine—kidney cancer	0.000214	0.000387	CcSEcCtD
Entacapone—Asthenia—Dactinomycin—kidney cancer	0.000214	0.000387	CcSEcCtD
Entacapone—COMT—Metabolism—SLC5A3—kidney cancer	0.000213	0.00249	CbGpPWpGaD
Entacapone—COMT—Metabolism—PGK1—kidney cancer	0.000213	0.00249	CbGpPWpGaD
Entacapone—Confusional state—Paclitaxel—kidney cancer	0.000213	0.000386	CcSEcCtD
Entacapone—Blood creatinine increased—Doxorubicin—kidney cancer	0.000213	0.000386	CcSEcCtD
Entacapone—Malnutrition—Capecitabine—kidney cancer	0.000213	0.000385	CcSEcCtD
Entacapone—Oedema—Paclitaxel—kidney cancer	0.000211	0.000382	CcSEcCtD
Entacapone—Abdominal pain—Vincristine—kidney cancer	0.00021	0.000381	CcSEcCtD
Entacapone—Body temperature increased—Vincristine—kidney cancer	0.00021	0.000381	CcSEcCtD
Entacapone—Flatulence—Capecitabine—kidney cancer	0.000209	0.000379	CcSEcCtD
Entacapone—COMT—Metabolism—LDHB—kidney cancer	0.000209	0.00245	CbGpPWpGaD
Entacapone—Dysgeusia—Capecitabine—kidney cancer	0.000208	0.000377	CcSEcCtD
Entacapone—Dizziness—Sunitinib—kidney cancer	0.000208	0.000376	CcSEcCtD
Entacapone—Feeling abnormal—Gemcitabine—kidney cancer	0.000208	0.000376	CcSEcCtD
Entacapone—Shock—Paclitaxel—kidney cancer	0.000208	0.000376	CcSEcCtD
Entacapone—Vomiting—Sorafenib—kidney cancer	0.000208	0.000376	CcSEcCtD
Entacapone—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000208	0.000376	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000208	0.00243	CbGpPWpGaD
Entacapone—Nervous system disorder—Paclitaxel—kidney cancer	0.000207	0.000375	CcSEcCtD
Entacapone—UGT1A9—Metabolism—PDHB—kidney cancer	0.000207	0.00242	CbGpPWpGaD
Entacapone—Thrombocytopenia—Paclitaxel—kidney cancer	0.000207	0.000374	CcSEcCtD
Entacapone—UGT1A9—Biological oxidations—POMC—kidney cancer	0.000206	0.00241	CbGpPWpGaD
Entacapone—Rash—Sorafenib—kidney cancer	0.000206	0.000373	CcSEcCtD
Entacapone—Dermatitis—Sorafenib—kidney cancer	0.000206	0.000373	CcSEcCtD
Entacapone—Back pain—Capecitabine—kidney cancer	0.000206	0.000372	CcSEcCtD
Entacapone—Skin disorder—Paclitaxel—kidney cancer	0.000205	0.000371	CcSEcCtD
Entacapone—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000205	0.000371	CcSEcCtD
Entacapone—Headache—Sorafenib—kidney cancer	0.000205	0.000371	CcSEcCtD
Entacapone—Muscle spasms—Capecitabine—kidney cancer	0.000204	0.00037	CcSEcCtD
Entacapone—Hyperhidrosis—Paclitaxel—kidney cancer	0.000204	0.00037	CcSEcCtD
Entacapone—Diarrhoea—Dactinomycin—kidney cancer	0.000204	0.000369	CcSEcCtD
Entacapone—Anorexia—Paclitaxel—kidney cancer	0.000201	0.000365	CcSEcCtD
Entacapone—Gastritis—Doxorubicin—kidney cancer	0.000201	0.000364	CcSEcCtD
Entacapone—Muscular weakness—Doxorubicin—kidney cancer	0.000201	0.000363	CcSEcCtD
Entacapone—Vision blurred—Capecitabine—kidney cancer	0.0002	0.000362	CcSEcCtD
Entacapone—Vomiting—Sunitinib—kidney cancer	0.0002	0.000362	CcSEcCtD
Entacapone—Body temperature increased—Gemcitabine—kidney cancer	0.0002	0.000361	CcSEcCtD
Entacapone—Tremor—Capecitabine—kidney cancer	0.000199	0.00036	CcSEcCtD
Entacapone—Rash—Sunitinib—kidney cancer	0.000198	0.000359	CcSEcCtD
Entacapone—Dermatitis—Sunitinib—kidney cancer	0.000198	0.000359	CcSEcCtD
Entacapone—Hypotension—Paclitaxel—kidney cancer	0.000197	0.000357	CcSEcCtD
Entacapone—Ill-defined disorder—Capecitabine—kidney cancer	0.000197	0.000357	CcSEcCtD
Entacapone—Headache—Sunitinib—kidney cancer	0.000197	0.000357	CcSEcCtD
Entacapone—Dysphagia—Doxorubicin—kidney cancer	0.000197	0.000356	CcSEcCtD
Entacapone—Hypersensitivity—Vincristine—kidney cancer	0.000196	0.000355	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CCBL1—kidney cancer	0.000195	0.00227	CbGpPWpGaD
Entacapone—Nausea—Sorafenib—kidney cancer	0.000194	0.000351	CcSEcCtD
Entacapone—COMT—Neuronal System—RAF1—kidney cancer	0.000193	0.00225	CbGpPWpGaD
Entacapone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000193	0.000348	CcSEcCtD
Entacapone—Malaise—Capecitabine—kidney cancer	0.000192	0.000347	CcSEcCtD
Entacapone—Angina pectoris—Doxorubicin—kidney cancer	0.000192	0.000347	CcSEcCtD
Entacapone—Insomnia—Paclitaxel—kidney cancer	0.000191	0.000346	CcSEcCtD
Entacapone—Vertigo—Capecitabine—kidney cancer	0.000191	0.000345	CcSEcCtD
Entacapone—Asthenia—Vincristine—kidney cancer	0.000191	0.000345	CcSEcCtD
Entacapone—Syncope—Capecitabine—kidney cancer	0.000191	0.000345	CcSEcCtD
Entacapone—Leukopenia—Capecitabine—kidney cancer	0.00019	0.000344	CcSEcCtD
Entacapone—Paraesthesia—Paclitaxel—kidney cancer	0.00019	0.000343	CcSEcCtD
Entacapone—Vomiting—Dactinomycin—kidney cancer	0.000189	0.000343	CcSEcCtD
Entacapone—Dyspnoea—Paclitaxel—kidney cancer	0.000188	0.000341	CcSEcCtD
Entacapone—Somnolence—Paclitaxel—kidney cancer	0.000188	0.00034	CcSEcCtD
Entacapone—Palpitations—Capecitabine—kidney cancer	0.000188	0.00034	CcSEcCtD
Entacapone—Rash—Dactinomycin—kidney cancer	0.000188	0.00034	CcSEcCtD
Entacapone—Nausea—Sunitinib—kidney cancer	0.000187	0.000338	CcSEcCtD
Entacapone—Loss of consciousness—Capecitabine—kidney cancer	0.000187	0.000338	CcSEcCtD
Entacapone—Dyspepsia—Paclitaxel—kidney cancer	0.000186	0.000337	CcSEcCtD
Entacapone—Cough—Capecitabine—kidney cancer	0.000185	0.000336	CcSEcCtD
Entacapone—Dysuria—Doxorubicin—kidney cancer	0.000184	0.000333	CcSEcCtD
Entacapone—Decreased appetite—Paclitaxel—kidney cancer	0.000184	0.000332	CcSEcCtD
Entacapone—Hypertension—Capecitabine—kidney cancer	0.000183	0.000332	CcSEcCtD
Entacapone—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000183	0.000331	CcSEcCtD
Entacapone—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000182	0.00033	CcSEcCtD
Entacapone—Fatigue—Paclitaxel—kidney cancer	0.000182	0.00033	CcSEcCtD
Entacapone—Diarrhoea—Vincristine—kidney cancer	0.000182	0.000329	CcSEcCtD
Entacapone—Pollakiuria—Doxorubicin—kidney cancer	0.000182	0.000329	CcSEcCtD
Entacapone—COMT—Metabolism—CA9—kidney cancer	0.000181	0.00212	CbGpPWpGaD
Entacapone—Asthenia—Gemcitabine—kidney cancer	0.000181	0.000328	CcSEcCtD
Entacapone—Chest pain—Capecitabine—kidney cancer	0.000181	0.000327	CcSEcCtD
Entacapone—Myalgia—Capecitabine—kidney cancer	0.000181	0.000327	CcSEcCtD
Entacapone—Pain—Paclitaxel—kidney cancer	0.000181	0.000327	CcSEcCtD
Entacapone—Constipation—Paclitaxel—kidney cancer	0.000181	0.000327	CcSEcCtD
Entacapone—Anxiety—Capecitabine—kidney cancer	0.00018	0.000326	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00018	0.000325	CcSEcCtD
Entacapone—Weight increased—Doxorubicin—kidney cancer	0.000179	0.000324	CcSEcCtD
Entacapone—Discomfort—Capecitabine—kidney cancer	0.000179	0.000323	CcSEcCtD
Entacapone—Pruritus—Gemcitabine—kidney cancer	0.000179	0.000323	CcSEcCtD
Entacapone—Weight decreased—Doxorubicin—kidney cancer	0.000178	0.000322	CcSEcCtD
Entacapone—Hyperglycaemia—Doxorubicin—kidney cancer	0.000177	0.000321	CcSEcCtD
Entacapone—Dry mouth—Capecitabine—kidney cancer	0.000177	0.00032	CcSEcCtD
Entacapone—Nausea—Dactinomycin—kidney cancer	0.000177	0.00032	CcSEcCtD
Entacapone—Pneumonia—Doxorubicin—kidney cancer	0.000176	0.000319	CcSEcCtD
Entacapone—Dizziness—Vincristine—kidney cancer	0.000176	0.000318	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000176	0.00206	CbGpPWpGaD
Entacapone—Confusional state—Capecitabine—kidney cancer	0.000175	0.000316	CcSEcCtD
Entacapone—Feeling abnormal—Paclitaxel—kidney cancer	0.000174	0.000315	CcSEcCtD
Entacapone—Oedema—Capecitabine—kidney cancer	0.000173	0.000314	CcSEcCtD
Entacapone—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000173	0.000313	CcSEcCtD
Entacapone—Diarrhoea—Gemcitabine—kidney cancer	0.000173	0.000313	CcSEcCtD
Entacapone—COMT—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000173	0.00202	CbGpPWpGaD
Entacapone—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000172	0.000311	CcSEcCtD
Entacapone—Shock—Capecitabine—kidney cancer	0.000171	0.000309	CcSEcCtD
Entacapone—Conjunctivitis—Doxorubicin—kidney cancer	0.00017	0.000308	CcSEcCtD
Entacapone—Urinary tract infection—Doxorubicin—kidney cancer	0.00017	0.000308	CcSEcCtD
Entacapone—Nervous system disorder—Capecitabine—kidney cancer	0.00017	0.000308	CcSEcCtD
Entacapone—Thrombocytopenia—Capecitabine—kidney cancer	0.00017	0.000307	CcSEcCtD
Entacapone—Vomiting—Vincristine—kidney cancer	0.000169	0.000306	CcSEcCtD
Entacapone—UGT1A9—Metabolism—GLIPR1—kidney cancer	0.000169	0.00197	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PPAT—kidney cancer	0.000169	0.00197	CbGpPWpGaD
Entacapone—Skin disorder—Capecitabine—kidney cancer	0.000168	0.000305	CcSEcCtD
Entacapone—Sweating—Doxorubicin—kidney cancer	0.000168	0.000304	CcSEcCtD
Entacapone—Urticaria—Paclitaxel—kidney cancer	0.000168	0.000304	CcSEcCtD
Entacapone—Rash—Vincristine—kidney cancer	0.000168	0.000304	CcSEcCtD
Entacapone—Hyperhidrosis—Capecitabine—kidney cancer	0.000168	0.000303	CcSEcCtD
Entacapone—Dermatitis—Vincristine—kidney cancer	0.000168	0.000303	CcSEcCtD
Entacapone—Haematuria—Doxorubicin—kidney cancer	0.000167	0.000302	CcSEcCtD
Entacapone—Body temperature increased—Paclitaxel—kidney cancer	0.000167	0.000302	CcSEcCtD
Entacapone—Abdominal pain—Paclitaxel—kidney cancer	0.000167	0.000302	CcSEcCtD
Entacapone—Headache—Vincristine—kidney cancer	0.000167	0.000302	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000167	0.00195	CbGpPWpGaD
Entacapone—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000166	0.0003	CcSEcCtD
Entacapone—Epistaxis—Doxorubicin—kidney cancer	0.000165	0.000299	CcSEcCtD
Entacapone—Anorexia—Capecitabine—kidney cancer	0.000165	0.000299	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000165	0.00193	CbGpPWpGaD
Entacapone—Sinusitis—Doxorubicin—kidney cancer	0.000164	0.000298	CcSEcCtD
Entacapone—Agranulocytosis—Doxorubicin—kidney cancer	0.000164	0.000296	CcSEcCtD
Entacapone—Hypotension—Capecitabine—kidney cancer	0.000162	0.000293	CcSEcCtD
Entacapone—Vomiting—Gemcitabine—kidney cancer	0.000161	0.00029	CcSEcCtD
Entacapone—Bradycardia—Doxorubicin—kidney cancer	0.00016	0.00029	CcSEcCtD
Entacapone—Rash—Gemcitabine—kidney cancer	0.000159	0.000288	CcSEcCtD
Entacapone—Dermatitis—Gemcitabine—kidney cancer	0.000159	0.000288	CcSEcCtD
Entacapone—Haemoglobin—Doxorubicin—kidney cancer	0.000158	0.000286	CcSEcCtD
Entacapone—Headache—Gemcitabine—kidney cancer	0.000158	0.000286	CcSEcCtD
Entacapone—Nausea—Vincristine—kidney cancer	0.000158	0.000286	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000158	0.000286	CcSEcCtD
Entacapone—Hepatitis—Doxorubicin—kidney cancer	0.000157	0.000285	CcSEcCtD
Entacapone—Haemorrhage—Doxorubicin—kidney cancer	0.000157	0.000285	CcSEcCtD
Entacapone—Insomnia—Capecitabine—kidney cancer	0.000157	0.000284	CcSEcCtD
Entacapone—UGT1A9—Metabolism—FH—kidney cancer	0.000157	0.00183	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—APRT—kidney cancer	0.000157	0.00183	CbGpPWpGaD
Entacapone—Hypoaesthesia—Doxorubicin—kidney cancer	0.000157	0.000283	CcSEcCtD
Entacapone—Pharyngitis—Doxorubicin—kidney cancer	0.000156	0.000283	CcSEcCtD
Entacapone—Paraesthesia—Capecitabine—kidney cancer	0.000156	0.000282	CcSEcCtD
Entacapone—Hypersensitivity—Paclitaxel—kidney cancer	0.000156	0.000282	CcSEcCtD
Entacapone—Urinary tract disorder—Doxorubicin—kidney cancer	0.000155	0.000281	CcSEcCtD
Entacapone—Dyspnoea—Capecitabine—kidney cancer	0.000155	0.00028	CcSEcCtD
Entacapone—COMT—Metabolism—CRABP1—kidney cancer	0.000154	0.0018	CbGpPWpGaD
Entacapone—Urethral disorder—Doxorubicin—kidney cancer	0.000154	0.000279	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000153	0.00179	CbGpPWpGaD
Entacapone—Dyspepsia—Capecitabine—kidney cancer	0.000153	0.000276	CcSEcCtD
Entacapone—Visual impairment—Doxorubicin—kidney cancer	0.000152	0.000274	CcSEcCtD
Entacapone—Asthenia—Paclitaxel—kidney cancer	0.000152	0.000274	CcSEcCtD
Entacapone—Decreased appetite—Capecitabine—kidney cancer	0.000151	0.000273	CcSEcCtD
Entacapone—Nausea—Gemcitabine—kidney cancer	0.00015	0.000271	CcSEcCtD
Entacapone—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00015	0.000271	CcSEcCtD
Entacapone—Fatigue—Capecitabine—kidney cancer	0.00015	0.000271	CcSEcCtD
Entacapone—Pruritus—Paclitaxel—kidney cancer	0.00015	0.000271	CcSEcCtD
Entacapone—Erythema multiforme—Doxorubicin—kidney cancer	0.000149	0.000269	CcSEcCtD
Entacapone—Pain—Capecitabine—kidney cancer	0.000148	0.000268	CcSEcCtD
Entacapone—Constipation—Capecitabine—kidney cancer	0.000148	0.000268	CcSEcCtD
Entacapone—UGT1A9—Metabolism—GPC3—kidney cancer	0.000147	0.00172	CbGpPWpGaD
Entacapone—Eye disorder—Doxorubicin—kidney cancer	0.000147	0.000266	CcSEcCtD
Entacapone—Flushing—Doxorubicin—kidney cancer	0.000146	0.000264	CcSEcCtD
Entacapone—Cardiac disorder—Doxorubicin—kidney cancer	0.000146	0.000264	CcSEcCtD
Entacapone—Diarrhoea—Paclitaxel—kidney cancer	0.000145	0.000262	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CA2—kidney cancer	0.000143	0.00168	CbGpPWpGaD
Entacapone—COMT—Metabolism—ITPR2—kidney cancer	0.000143	0.00168	CbGpPWpGaD
Entacapone—Feeling abnormal—Capecitabine—kidney cancer	0.000143	0.000259	CcSEcCtD
Entacapone—Gastrointestinal pain—Capecitabine—kidney cancer	0.000142	0.000257	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ALAD—kidney cancer	0.00014	0.00163	CbGpPWpGaD
Entacapone—Dizziness—Paclitaxel—kidney cancer	0.00014	0.000253	CcSEcCtD
Entacapone—Alopecia—Doxorubicin—kidney cancer	0.000139	0.000252	CcSEcCtD
Entacapone—Mental disorder—Doxorubicin—kidney cancer	0.000138	0.000249	CcSEcCtD
Entacapone—Urticaria—Capecitabine—kidney cancer	0.000138	0.000249	CcSEcCtD
Entacapone—Abdominal pain—Capecitabine—kidney cancer	0.000137	0.000248	CcSEcCtD
Entacapone—Body temperature increased—Capecitabine—kidney cancer	0.000137	0.000248	CcSEcCtD
Entacapone—Malnutrition—Doxorubicin—kidney cancer	0.000137	0.000248	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ST3GAL2—kidney cancer	0.000136	0.00159	CbGpPWpGaD
Entacapone—Flatulence—Doxorubicin—kidney cancer	0.000135	0.000244	CcSEcCtD
Entacapone—Tension—Doxorubicin—kidney cancer	0.000134	0.000243	CcSEcCtD
Entacapone—Vomiting—Paclitaxel—kidney cancer	0.000134	0.000243	CcSEcCtD
Entacapone—Dysgeusia—Doxorubicin—kidney cancer	0.000134	0.000243	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ALDH1A1—kidney cancer	0.000133	0.00156	CbGpPWpGaD
Entacapone—Rash—Paclitaxel—kidney cancer	0.000133	0.000241	CcSEcCtD
Entacapone—Dermatitis—Paclitaxel—kidney cancer	0.000133	0.000241	CcSEcCtD
Entacapone—Nervousness—Doxorubicin—kidney cancer	0.000133	0.000241	CcSEcCtD
Entacapone—Back pain—Doxorubicin—kidney cancer	0.000133	0.00024	CcSEcCtD
Entacapone—Headache—Paclitaxel—kidney cancer	0.000132	0.00024	CcSEcCtD
Entacapone—COMT—Neuronal System—MAPK1—kidney cancer	0.000132	0.00155	CbGpPWpGaD
Entacapone—Muscle spasms—Doxorubicin—kidney cancer	0.000132	0.000238	CcSEcCtD
Entacapone—COMT—Metabolism—ACHE—kidney cancer	0.000131	0.00153	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTT1—kidney cancer	0.000131	0.00153	CbGpPWpGaD
Entacapone—Vision blurred—Doxorubicin—kidney cancer	0.000129	0.000234	CcSEcCtD
Entacapone—UGT1A9—Metabolism—PGK1—kidney cancer	0.000128	0.00149	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLC5A3—kidney cancer	0.000128	0.00149	CbGpPWpGaD
Entacapone—Hypersensitivity—Capecitabine—kidney cancer	0.000128	0.000231	CcSEcCtD
Entacapone—Ill-defined disorder—Doxorubicin—kidney cancer	0.000127	0.00023	CcSEcCtD
Entacapone—Agitation—Doxorubicin—kidney cancer	0.000126	0.000228	CcSEcCtD
Entacapone—Nausea—Paclitaxel—kidney cancer	0.000126	0.000227	CcSEcCtD
Entacapone—UGT1A9—Metabolism—LDHB—kidney cancer	0.000125	0.00147	CbGpPWpGaD
Entacapone—Asthenia—Capecitabine—kidney cancer	0.000124	0.000225	CcSEcCtD
Entacapone—COMT—Metabolism—SCARB1—kidney cancer	0.000124	0.00145	CbGpPWpGaD
Entacapone—Malaise—Doxorubicin—kidney cancer	0.000124	0.000224	CcSEcCtD
Entacapone—Vertigo—Doxorubicin—kidney cancer	0.000123	0.000223	CcSEcCtD
Entacapone—Syncope—Doxorubicin—kidney cancer	0.000123	0.000222	CcSEcCtD
Entacapone—Pruritus—Capecitabine—kidney cancer	0.000123	0.000222	CcSEcCtD
Entacapone—Leukopenia—Doxorubicin—kidney cancer	0.000123	0.000222	CcSEcCtD
Entacapone—COMT—Metabolism—PTGS1—kidney cancer	0.000123	0.00143	CbGpPWpGaD
Entacapone—Palpitations—Doxorubicin—kidney cancer	0.000121	0.000219	CcSEcCtD
Entacapone—Loss of consciousness—Doxorubicin—kidney cancer	0.00012	0.000218	CcSEcCtD
Entacapone—COMT—Metabolism—PSMD7—kidney cancer	0.00012	0.0014	CbGpPWpGaD
Entacapone—Cough—Doxorubicin—kidney cancer	0.00012	0.000216	CcSEcCtD
Entacapone—Convulsion—Doxorubicin—kidney cancer	0.000119	0.000215	CcSEcCtD
Entacapone—Diarrhoea—Capecitabine—kidney cancer	0.000119	0.000215	CcSEcCtD
Entacapone—Hypertension—Doxorubicin—kidney cancer	0.000118	0.000214	CcSEcCtD
Entacapone—Myalgia—Doxorubicin—kidney cancer	0.000117	0.000211	CcSEcCtD
Entacapone—Chest pain—Doxorubicin—kidney cancer	0.000117	0.000211	CcSEcCtD
Entacapone—Anxiety—Doxorubicin—kidney cancer	0.000116	0.00021	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000116	0.00021	CcSEcCtD
Entacapone—Discomfort—Doxorubicin—kidney cancer	0.000115	0.000209	CcSEcCtD
Entacapone—Dizziness—Capecitabine—kidney cancer	0.000115	0.000208	CcSEcCtD
Entacapone—Dry mouth—Doxorubicin—kidney cancer	0.000114	0.000206	CcSEcCtD
Entacapone—COMT—Metabolism—BCHE—kidney cancer	0.000114	0.00133	CbGpPWpGaD
Entacapone—Confusional state—Doxorubicin—kidney cancer	0.000113	0.000204	CcSEcCtD
Entacapone—COMT—Metabolism—SLC5A5—kidney cancer	0.000113	0.00132	CbGpPWpGaD
Entacapone—Oedema—Doxorubicin—kidney cancer	0.000112	0.000202	CcSEcCtD
Entacapone—Vomiting—Capecitabine—kidney cancer	0.00011	0.0002	CcSEcCtD
Entacapone—Shock—Doxorubicin—kidney cancer	0.00011	0.000199	CcSEcCtD
Entacapone—Nervous system disorder—Doxorubicin—kidney cancer	0.00011	0.000198	CcSEcCtD
Entacapone—Thrombocytopenia—Doxorubicin—kidney cancer	0.000109	0.000198	CcSEcCtD
Entacapone—Rash—Capecitabine—kidney cancer	0.000109	0.000198	CcSEcCtD
Entacapone—Dermatitis—Capecitabine—kidney cancer	0.000109	0.000198	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CA9—kidney cancer	0.000109	0.00127	CbGpPWpGaD
Entacapone—COMT—Metabolism—SLC2A1—kidney cancer	0.000109	0.00127	CbGpPWpGaD
Entacapone—Headache—Capecitabine—kidney cancer	0.000109	0.000197	CcSEcCtD
Entacapone—Skin disorder—Doxorubicin—kidney cancer	0.000109	0.000197	CcSEcCtD
Entacapone—Hyperhidrosis—Doxorubicin—kidney cancer	0.000108	0.000196	CcSEcCtD
Entacapone—Anorexia—Doxorubicin—kidney cancer	0.000107	0.000193	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000106	0.00124	CbGpPWpGaD
Entacapone—Hypotension—Doxorubicin—kidney cancer	0.000104	0.000189	CcSEcCtD
Entacapone—Nausea—Capecitabine—kidney cancer	0.000103	0.000186	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000102	0.000184	CcSEcCtD
Entacapone—Insomnia—Doxorubicin—kidney cancer	0.000101	0.000183	CcSEcCtD
Entacapone—Paraesthesia—Doxorubicin—kidney cancer	0.0001	0.000182	CcSEcCtD
Entacapone—Dyspnoea—Doxorubicin—kidney cancer	9.97e-05	0.00018	CcSEcCtD
Entacapone—Somnolence—Doxorubicin—kidney cancer	9.94e-05	0.00018	CcSEcCtD
Entacapone—Dyspepsia—Doxorubicin—kidney cancer	9.84e-05	0.000178	CcSEcCtD
Entacapone—Decreased appetite—Doxorubicin—kidney cancer	9.72e-05	0.000176	CcSEcCtD
Entacapone—Gastrointestinal disorder—Doxorubicin—kidney cancer	9.65e-05	0.000175	CcSEcCtD
Entacapone—Fatigue—Doxorubicin—kidney cancer	9.64e-05	0.000174	CcSEcCtD
Entacapone—Pain—Doxorubicin—kidney cancer	9.56e-05	0.000173	CcSEcCtD
Entacapone—Constipation—Doxorubicin—kidney cancer	9.56e-05	0.000173	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CRABP1—kidney cancer	9.24e-05	0.00108	CbGpPWpGaD
Entacapone—Feeling abnormal—Doxorubicin—kidney cancer	9.21e-05	0.000167	CcSEcCtD
Entacapone—Gastrointestinal pain—Doxorubicin—kidney cancer	9.14e-05	0.000165	CcSEcCtD
Entacapone—COMT—Metabolism—GSTP1—kidney cancer	9.07e-05	0.00106	CbGpPWpGaD
Entacapone—Urticaria—Doxorubicin—kidney cancer	8.88e-05	0.000161	CcSEcCtD
Entacapone—Body temperature increased—Doxorubicin—kidney cancer	8.84e-05	0.00016	CcSEcCtD
Entacapone—Abdominal pain—Doxorubicin—kidney cancer	8.84e-05	0.00016	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ITPR2—kidney cancer	8.59e-05	0.001	CbGpPWpGaD
Entacapone—COMT—Metabolism—ABCB1—kidney cancer	8.58e-05	0.001	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTM1—kidney cancer	8.33e-05	0.000974	CbGpPWpGaD
Entacapone—Hypersensitivity—Doxorubicin—kidney cancer	8.24e-05	0.000149	CcSEcCtD
Entacapone—Asthenia—Doxorubicin—kidney cancer	8.02e-05	0.000145	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.92e-05	0.000926	CbGpPWpGaD
Entacapone—Pruritus—Doxorubicin—kidney cancer	7.91e-05	0.000143	CcSEcCtD
Entacapone—COMT—Metabolism—CYP1A1—kidney cancer	7.9e-05	0.000923	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ACHE—kidney cancer	7.84e-05	0.000916	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTT1—kidney cancer	7.84e-05	0.000916	CbGpPWpGaD
Entacapone—Diarrhoea—Doxorubicin—kidney cancer	7.65e-05	0.000138	CcSEcCtD
Entacapone—UGT1A9—Metabolism—SCARB1—kidney cancer	7.42e-05	0.000867	CbGpPWpGaD
Entacapone—Dizziness—Doxorubicin—kidney cancer	7.39e-05	0.000134	CcSEcCtD
Entacapone—UGT1A9—Metabolism—PTGS1—kidney cancer	7.34e-05	0.000858	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PSMD7—kidney cancer	7.2e-05	0.000842	CbGpPWpGaD
Entacapone—Vomiting—Doxorubicin—kidney cancer	7.11e-05	0.000129	CcSEcCtD
Entacapone—Rash—Doxorubicin—kidney cancer	7.05e-05	0.000128	CcSEcCtD
Entacapone—Dermatitis—Doxorubicin—kidney cancer	7.04e-05	0.000127	CcSEcCtD
Entacapone—Headache—Doxorubicin—kidney cancer	7e-05	0.000127	CcSEcCtD
Entacapone—UGT1A9—Metabolism—BCHE—kidney cancer	6.83e-05	0.000798	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLC5A5—kidney cancer	6.74e-05	0.000788	CbGpPWpGaD
Entacapone—Nausea—Doxorubicin—kidney cancer	6.64e-05	0.00012	CcSEcCtD
Entacapone—UGT1A9—Metabolism—SLC2A1—kidney cancer	6.51e-05	0.000761	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.32e-05	0.000738	CbGpPWpGaD
Entacapone—COMT—Metabolism—POMC—kidney cancer	5.89e-05	0.000688	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.51e-05	0.000644	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTP1—kidney cancer	5.43e-05	0.000635	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ABCB1—kidney cancer	5.14e-05	0.000601	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTM1—kidney cancer	4.99e-05	0.000583	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP1A1—kidney cancer	4.73e-05	0.000553	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTGS2—kidney cancer	4.7e-05	0.000549	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTEN—kidney cancer	4.1e-05	0.000479	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.89e-05	0.000454	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—POMC—kidney cancer	3.53e-05	0.000412	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CA—kidney cancer	2.89e-05	0.000338	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTGS2—kidney cancer	2.81e-05	0.000329	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTEN—kidney cancer	2.45e-05	0.000287	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CA—kidney cancer	1.73e-05	0.000202	CbGpPWpGaD
